J.W.J.W.HarperJ.W.J.W., G.R.G.R.AdamiG.R.G.R., N.N.WeiN.N., K.K.KeyomarsiK.K., S.J.S.J.ElledgeS.J.S.J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, „Cell”, 75 (4), 1993, s. 805–816, DOI:10.1016/0092-8674(93)90499-g, PMID:8242751(ang.).
W. S. el-Deiry, T.T.TokinoT.T., V.E.V.E.VelculescuV.E.V.E., D.B.D.B.LevyD.B.D.B., R.R.ParsonsR.R., WAF1, a potential mediator of p53 tumor suppression, „Cell”, 75 (4), 1993, s. 817–825, DOI:10.1016/0092-8674(93)90500-p, PMID:8242752(ang.).
Y.Y.LiY.Y., C.W.C.W.JenkinsC.W.C.W., M.A.M.A.NicholsM.A.M.A., Y.Y.XiongY.Y., Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21, „Oncogene”, 9 (8), 1994, s. 2261–2268, DOI:10.1074/jbc.M102240200, PMID:7913544(ang.).
Andrei L.A.L.GartelAndrei L.A.L., Senthil K.S.K.RadhakrishnanSenthil K.S.K., Lost in transcription: p21 repression, mechanisms, and consequences, „Cancer Research”, 65 (10), 2005, s. 3980–3985, DOI:10.1158/0008-5472.CAN-04-3995, PMID:15899785(ang.).
B.B.AnB.B., R.H.R.H.GoldfarbR.H.R.H., R.R.SimanR.R., Q.P.Q.P.DouQ.P.Q.P., Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts, „Cell Death and Differentiation”, 5 (12), 1998, s. 1062–1075, DOI:10.1038/sj.cdd.4400436, PMID:9894613(ang.).
J.B.J.B.AlmondJ.B.J.B., G.M.G.M.CohenG.M.G.M., The proteasome: a novel target for cancer chemotherapy, „Leukemia”, 16 (4), 2002, s. 433–443, DOI:10.1038/sj.leu.2402417, PMID:11960320(ang.).
ReneR.RodriguezReneR., MarkM.MeuthMarkM., Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress, „Molecular Biology of the Cell”, 17 (1), 2006, s. 402–412, DOI:10.1091/mbc.e05-07-0594, PMID:16280359, PMCID:PMC1345677(ang.).
JielinJ.ZhangJielinJ., David T.D.T.ScaddenDavid T.D.T., Clyde S.C.S.CrumpackerClyde S.C.S., Primitive hematopoietic cells resist HIV-1 infection via p21, „The Journal of Clinical Investigation”, 117 (2), 2007, s. 473–481, DOI:10.1172/JCI28971, PMID:17273559, PMCID:PMC1783820(ang.).
T.T.OnoT.T., H.H.KitauraH.H., H.H.UgaiH.H., T.T.MurataT.T., K.K.K.K.YokoyamaK.K.K.K., TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase, „Journal of Biological Chemistry”, 275 (40), 2000, s. 31145–31154, DOI:10.1074/jbc.M003031200, PMID:10878006(ang.).
K.K.MitsuiK.K., A.A.MatsumotoA.A., S.S.OhtsukaS.S., M.M.OhtsuboM.M., A.A.YoshimuraA.A., Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1, „Biochemical and Biophysical Research Communications”, 264 (2), 1999, s. 457–464, DOI:10.1006/bbrc.1999.1516, PMID:10529385(ang.).
TarekT.AbbasTarekT., UmaU.SivaprasadUmaU., KentaK.TeraiKentaK., VirginiaV.AmadorVirginiaV., MicheleM.PaganoMicheleM., PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex, „Genes & Development”, 22 (18), 2008, s. 2496–2506, DOI:10.1101/gad.1676108, PMID:18794347, PMCID:PMC2546691(ang.).
Brian K.B.K.LawBrian K.B.K., AnnaA.ChytilAnnaA., NancyN.DumontNancyN., Elizabeth G.E.G.HamiltonElizabeth G.E.G., Mary E.M.E.Waltner-LawMary E.M.E., Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells, „Molecular and Cellular Biology”, 22 (23), 2002, s. 8184–8198, DOI:10.1128/mcb.22.23.8184-8198.2002, PMID:12417722, PMCID:PMC134072(ang.).
C.H.C.H.YamC.H.C.H., R.W.R.W.NgR.W.R.W., W.Y.W.Y.SiuW.Y.W.Y., A.W.A.W.LauA.W.A.W., R.Y.R.Y.PoonR.Y.R.Y., Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2, „Molecular and Cellular Biology”, 19 (1), 1999, s. 635–645, DOI:10.1128/mcb.19.1.635, PMID:9858587, PMCID:PMC83921(ang.).
H.H.ZhaoH.H., S.S.JinS.S., M.J.M.J.AntinoreM.J.M.J., F.D.F.D.LungF.D.F.D., F.F.FanF.F., The central region of Gadd45 is required for its interaction with p21/WAF1, „Experimental Cell Research”, 258 (1), 2000, s. 92–100, DOI:10.1006/excr.2000.4906, PMID:10912791(ang.).
Q.Q.YangQ.Q., A.A.ManiconeA.A., J.D.J.D.CoursenJ.D.J.D., S.P.S.P.LinkeS.P.S.P., M.M.NagashimaM.M., Identification of a functional domain in a GADD45-mediated G2/M checkpoint, „Journal of Biological Chemistry”, 275 (47), 2000, s. 36892–36898, DOI:10.1074/jbc.M005319200, PMID:10973963(ang.).
N.N.AzamN.N., M.M.VairapandiM.M., W.W.ZhangW.W., B.B.HoffmanB.B., D.A.D.A.LiebermannD.A.D.A., Interaction of CR6 (GADD45gamma ) with proliferating cell nuclear antigen impedes negative growth control, „Journal of Biological Chemistry”, 276 (4), 2001, s. 2766–2774, DOI:10.1074/jbc.M005626200, PMID:11022036(ang.).
K.K.NakayamaK.K., T.T.HaraT.T., M.M.HibiM.M., T.T.HiranoT.T., A.A.MiyajimaA.A., A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth, „Journal of Biological Chemistry”, 274 (35), 1999, s. 24766–24772, DOI:10.1074/jbc.274.35.24766, PMID:10455148(ang.).
Jean-FrançoisJ.F.RualJean-FrançoisJ.F., KavithaK.VenkatesanKavithaK., TongT.HaoTongT., TomokoT.Hirozane-KishikawaTomokoT., AmélieA.DricotAmélieA., Towards a proteome-scale map of the human protein-protein interaction network, „Nature”, 437 (7062), 2005, s. 1173–1178, DOI:10.1038/nature04209, PMID:16189514(ang.).
IsabelleI.FrouinIsabelleI., GiovanniG.MagaGiovanniG., MarcoM.DenegriMarcoM., FedericaF.RivaFedericaF., MonicaM.SavioMonicaM., Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners, „Journal of Biological Chemistry”, 278 (41), 2003, s. 39265–39268, DOI:10.1074/jbc.C300098200, PMID:12930846(ang.).
R.R.FotedarR.R., R.R.MossiR.R., P.P.FitzgeraldP.P., T.T.RousselleT.T., G.G.MagaG.G., A conserved domain of the large subunit of replication factor C binds PCNA and acts like a dominant negative inhibitor of DNA replication in mammalian cells, „The EMBO journal”, 15 (16), 1996, s. 4423–4433, DOI:10.1002/j.1460-2075.1996.tb00815.x, PMID:8861969, PMCID:PMC452166(ang.).
Z.O.Z.O.JónssonZ.O.Z.O., R.R.HindgesR.R., U.U.HübscherU.U., Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen, „The EMBO journal”, 17 (8), 1998, s. 2412–2425, DOI:10.1093/emboj/17.8.2412, PMID:9545252, PMCID:PMC1170584(ang.).
J.M.J.M.GulbisJ.M.J.M., Z.Z.KelmanZ.Z., J.J.HurwitzJ.J., M.M.O'DonnellM.M., J.J.KuriyanJ.J., Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA, „Cell”, 87 (2), 1996, s. 297–306, DOI:10.1016/s0092-8674(00)81347-1, PMID:8861913(ang.).
R.R.TouitouR.R., J.J.RichardsonJ.J., S.S.BoseS.S., M.M.NakanishiM.M., J.J.RivettJ.J., A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome, „The EMBO journal”, 20 (10), 2001, s. 2367–2375, DOI:10.1093/emboj/20.10.2367, PMID:11350925, PMCID:PMC125454(ang.).
P.P.YuP.P., B.B.HuangB.B., M.M.ShenM.M., C.C.LauC.C., E.E.ChanE.E., p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues, „Oncogene”, 20 (4), 2001, s. 484–489, DOI:10.1038/sj.onc.1204113, PMID:11313979(ang.).
ZepingZ.WangZepingZ., NandiniN.BhattacharyaNandiniN., Philip F.P.F.MixterPhilip F.P.F., WenyiW.WeiWenyiW., JohnJ.SedivyJohnJ., Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase, „Biochimica et Biophysica Acta”, 1593 (1), 2002, s. 45–55, DOI:10.1016/s0167-4889(02)00347-6, PMID:12431783(ang.).
D.Y.D.Y.HuangD.Y.D.Y., Z.F.Z.F.ChangZ.F.Z.F., Interaction of human thymidine kinase 1 with p21(Waf1), „The Biochemical Journal”, 356 (Pt 3), 2001, s. 829–834, DOI:10.1042/0264-6021:3560829, PMID:11389691, PMCID:PMC1221910(ang.).
J.W.J.W.HarperJ.W.J.W., G.R.G.R.AdamiG.R.G.R., N.N.WeiN.N., K.K.KeyomarsiK.K., S.J.S.J.ElledgeS.J.S.J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, „Cell”, 75 (4), 1993, s. 805–816, DOI:10.1016/0092-8674(93)90499-g, PMID:8242751(ang.).
W. S. el-Deiry, T.T.TokinoT.T., V.E.V.E.VelculescuV.E.V.E., D.B.D.B.LevyD.B.D.B., R.R.ParsonsR.R., WAF1, a potential mediator of p53 tumor suppression, „Cell”, 75 (4), 1993, s. 817–825, DOI:10.1016/0092-8674(93)90500-p, PMID:8242752(ang.).
Y.Y.LiY.Y., C.W.C.W.JenkinsC.W.C.W., M.A.M.A.NicholsM.A.M.A., Y.Y.XiongY.Y., Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21, „Oncogene”, 9 (8), 1994, s. 2261–2268, DOI:10.1074/jbc.M102240200, PMID:7913544(ang.).
Andrei L.A.L.GartelAndrei L.A.L., Senthil K.S.K.RadhakrishnanSenthil K.S.K., Lost in transcription: p21 repression, mechanisms, and consequences, „Cancer Research”, 65 (10), 2005, s. 3980–3985, DOI:10.1158/0008-5472.CAN-04-3995, PMID:15899785(ang.).
B.B.AnB.B., R.H.R.H.GoldfarbR.H.R.H., R.R.SimanR.R., Q.P.Q.P.DouQ.P.Q.P., Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts, „Cell Death and Differentiation”, 5 (12), 1998, s. 1062–1075, DOI:10.1038/sj.cdd.4400436, PMID:9894613(ang.).
J.B.J.B.AlmondJ.B.J.B., G.M.G.M.CohenG.M.G.M., The proteasome: a novel target for cancer chemotherapy, „Leukemia”, 16 (4), 2002, s. 433–443, DOI:10.1038/sj.leu.2402417, PMID:11960320(ang.).
ReneR.RodriguezReneR., MarkM.MeuthMarkM., Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress, „Molecular Biology of the Cell”, 17 (1), 2006, s. 402–412, DOI:10.1091/mbc.e05-07-0594, PMID:16280359, PMCID:PMC1345677(ang.).
JielinJ.ZhangJielinJ., David T.D.T.ScaddenDavid T.D.T., Clyde S.C.S.CrumpackerClyde S.C.S., Primitive hematopoietic cells resist HIV-1 infection via p21, „The Journal of Clinical Investigation”, 117 (2), 2007, s. 473–481, DOI:10.1172/JCI28971, PMID:17273559, PMCID:PMC1783820(ang.).
T.T.OnoT.T., H.H.KitauraH.H., H.H.UgaiH.H., T.T.MurataT.T., K.K.K.K.YokoyamaK.K.K.K., TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase, „Journal of Biological Chemistry”, 275 (40), 2000, s. 31145–31154, DOI:10.1074/jbc.M003031200, PMID:10878006(ang.).
K.K.MitsuiK.K., A.A.MatsumotoA.A., S.S.OhtsukaS.S., M.M.OhtsuboM.M., A.A.YoshimuraA.A., Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1, „Biochemical and Biophysical Research Communications”, 264 (2), 1999, s. 457–464, DOI:10.1006/bbrc.1999.1516, PMID:10529385(ang.).
TarekT.AbbasTarekT., UmaU.SivaprasadUmaU., KentaK.TeraiKentaK., VirginiaV.AmadorVirginiaV., MicheleM.PaganoMicheleM., PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex, „Genes & Development”, 22 (18), 2008, s. 2496–2506, DOI:10.1101/gad.1676108, PMID:18794347, PMCID:PMC2546691(ang.).
Pamela P.P.P.McKenziePamela P.P.P., Mary K.M.K.DanksMary K.M.K., Richard W.R.W.KriwackiRichard W.R.W., Linda C.L.C.HarrisLinda C.L.C., P21Waf1/Cip1 dysfunction in neuroblastoma: a novel mechanism of attenuating G0-G1 cell cycle arrest, „Cancer Research”, 63 (13), 2003, s. 3840–3844, PMID:12839982(ang.).
Brian K.B.K.LawBrian K.B.K., AnnaA.ChytilAnnaA., NancyN.DumontNancyN., Elizabeth G.E.G.HamiltonElizabeth G.E.G., Mary E.M.E.Waltner-LawMary E.M.E., Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells, „Molecular and Cellular Biology”, 22 (23), 2002, s. 8184–8198, DOI:10.1128/mcb.22.23.8184-8198.2002, PMID:12417722, PMCID:PMC134072(ang.).
C.H.C.H.YamC.H.C.H., R.W.R.W.NgR.W.R.W., W.Y.W.Y.SiuW.Y.W.Y., A.W.A.W.LauA.W.A.W., R.Y.R.Y.PoonR.Y.R.Y., Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2, „Molecular and Cellular Biology”, 19 (1), 1999, s. 635–645, DOI:10.1128/mcb.19.1.635, PMID:9858587, PMCID:PMC83921(ang.).
H.H.ZhaoH.H., S.S.JinS.S., M.J.M.J.AntinoreM.J.M.J., F.D.F.D.LungF.D.F.D., F.F.FanF.F., The central region of Gadd45 is required for its interaction with p21/WAF1, „Experimental Cell Research”, 258 (1), 2000, s. 92–100, DOI:10.1006/excr.2000.4906, PMID:10912791(ang.).
Q.Q.YangQ.Q., A.A.ManiconeA.A., J.D.J.D.CoursenJ.D.J.D., S.P.S.P.LinkeS.P.S.P., M.M.NagashimaM.M., Identification of a functional domain in a GADD45-mediated G2/M checkpoint, „Journal of Biological Chemistry”, 275 (47), 2000, s. 36892–36898, DOI:10.1074/jbc.M005319200, PMID:10973963(ang.).
N.N.AzamN.N., M.M.VairapandiM.M., W.W.ZhangW.W., B.B.HoffmanB.B., D.A.D.A.LiebermannD.A.D.A., Interaction of CR6 (GADD45gamma ) with proliferating cell nuclear antigen impedes negative growth control, „Journal of Biological Chemistry”, 276 (4), 2001, s. 2766–2774, DOI:10.1074/jbc.M005626200, PMID:11022036(ang.).
K.K.NakayamaK.K., T.T.HaraT.T., M.M.HibiM.M., T.T.HiranoT.T., A.A.MiyajimaA.A., A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth, „Journal of Biological Chemistry”, 274 (35), 1999, s. 24766–24772, DOI:10.1074/jbc.274.35.24766, PMID:10455148(ang.).
Jean-FrançoisJ.F.RualJean-FrançoisJ.F., KavithaK.VenkatesanKavithaK., TongT.HaoTongT., TomokoT.Hirozane-KishikawaTomokoT., AmélieA.DricotAmélieA., Towards a proteome-scale map of the human protein-protein interaction network, „Nature”, 437 (7062), 2005, s. 1173–1178, DOI:10.1038/nature04209, PMID:16189514(ang.).
IsabelleI.FrouinIsabelleI., GiovanniG.MagaGiovanniG., MarcoM.DenegriMarcoM., FedericaF.RivaFedericaF., MonicaM.SavioMonicaM., Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners, „Journal of Biological Chemistry”, 278 (41), 2003, s. 39265–39268, DOI:10.1074/jbc.C300098200, PMID:12930846(ang.).
R.R.FotedarR.R., R.R.MossiR.R., P.P.FitzgeraldP.P., T.T.RousselleT.T., G.G.MagaG.G., A conserved domain of the large subunit of replication factor C binds PCNA and acts like a dominant negative inhibitor of DNA replication in mammalian cells, „The EMBO journal”, 15 (16), 1996, s. 4423–4433, DOI:10.1002/j.1460-2075.1996.tb00815.x, PMID:8861969, PMCID:PMC452166(ang.).
Z.O.Z.O.JónssonZ.O.Z.O., R.R.HindgesR.R., U.U.HübscherU.U., Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen, „The EMBO journal”, 17 (8), 1998, s. 2412–2425, DOI:10.1093/emboj/17.8.2412, PMID:9545252, PMCID:PMC1170584(ang.).
J.M.J.M.GulbisJ.M.J.M., Z.Z.KelmanZ.Z., J.J.HurwitzJ.J., M.M.O'DonnellM.M., J.J.KuriyanJ.J., Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA, „Cell”, 87 (2), 1996, s. 297–306, DOI:10.1016/s0092-8674(00)81347-1, PMID:8861913(ang.).
R.R.TouitouR.R., J.J.RichardsonJ.J., S.S.BoseS.S., M.M.NakanishiM.M., J.J.RivettJ.J., A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome, „The EMBO journal”, 20 (10), 2001, s. 2367–2375, DOI:10.1093/emboj/20.10.2367, PMID:11350925, PMCID:PMC125454(ang.).
P.P.YuP.P., B.B.HuangB.B., M.M.ShenM.M., C.C.LauC.C., E.E.ChanE.E., p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues, „Oncogene”, 20 (4), 2001, s. 484–489, DOI:10.1038/sj.onc.1204113, PMID:11313979(ang.).
ZepingZ.WangZepingZ., NandiniN.BhattacharyaNandiniN., Philip F.P.F.MixterPhilip F.P.F., WenyiW.WeiWenyiW., JohnJ.SedivyJohnJ., Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase, „Biochimica et Biophysica Acta”, 1593 (1), 2002, s. 45–55, DOI:10.1016/s0167-4889(02)00347-6, PMID:12431783(ang.).
D.Y.D.Y.HuangD.Y.D.Y., Z.F.Z.F.ChangZ.F.Z.F., Interaction of human thymidine kinase 1 with p21(Waf1), „The Biochemical Journal”, 356 (Pt 3), 2001, s. 829–834, DOI:10.1042/0264-6021:3560829, PMID:11389691, PMCID:PMC1221910(ang.).